These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8948605)
1. Differential effects of retinoic acid and N-(4-hydroxyphenyl)retinamide on head and neck squamous cell carcinoma cells. Eicher SA; Lotan R Laryngoscope; 1996 Dec; 106(12 Pt 1):1471-5. PubMed ID: 8948605 [TBL] [Abstract][Full Text] [Related]
2. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Oridate N; Lotan D; Xu XC; Hong WK; Lotan R Clin Cancer Res; 1996 May; 2(5):855-63. PubMed ID: 9816241 [TBL] [Abstract][Full Text] [Related]
3. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells. Sun SY; Yue P; Kelloff GJ; Steele VE; Lippman SM; Hong WK; Lotan R Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):595-601. PubMed ID: 11401908 [TBL] [Abstract][Full Text] [Related]
4. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines. Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096 [TBL] [Abstract][Full Text] [Related]
5. Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. Sun SY; Li W; Yue P; Lippman SM; Hong WK; Lotan R Cancer Res; 1999 May; 59(10):2493-8. PubMed ID: 10344763 [TBL] [Abstract][Full Text] [Related]
6. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines. Zou CP; Kurie JM; Lotan D; Zou CC; Hong WK; Lotan R Clin Cancer Res; 1998 May; 4(5):1345-55. PubMed ID: 9607596 [TBL] [Abstract][Full Text] [Related]
7. N-(4-hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells. Kim HJ; Chakravarti N; Oridate N; Choe C; Claret FX; Lotan R Oncogene; 2006 May; 25(19):2785-94. PubMed ID: 16407847 [TBL] [Abstract][Full Text] [Related]
8. Enhanced killing of SCC17B human head and neck squamous cell carcinoma cells after photodynamic therapy plus fenretinide via the de novo sphingolipid biosynthesis pathway and apoptosis. Boppana NB; Stochaj U; Kodiha M; Bielawska A; Bielawski J; Pierce JS; Korbelik M; Separovic D Int J Oncol; 2015 May; 46(5):2003-10. PubMed ID: 25739041 [TBL] [Abstract][Full Text] [Related]
9. Increased level of the p67phox subunit of NADPH oxidase by 4HPR in head and neck squamous carcinoma cells. Kim HJ; Oridate N; Lotan R Int J Oncol; 2005 Sep; 27(3):787-90. PubMed ID: 16077929 [TBL] [Abstract][Full Text] [Related]
10. Induction of endoplasmic reticulum stress by the pro-apoptotic retinoid N-(4-hydroxyphenyl)retinamide via a reactive oxygen species-dependent mechanism in human head and neck cancer cells. Kadara H; Lacroix L; Lotan D; Lotan R Cancer Biol Ther; 2007 May; 6(5):705-11. PubMed ID: 17404501 [TBL] [Abstract][Full Text] [Related]
11. Involvement of Rac in fenretinide-induced apoptosis. Kadara H; Tahara E; Kim HJ; Lotan D; Myers J; Lotan R Cancer Res; 2008 Jun; 68(11):4416-23. PubMed ID: 18519704 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression. Liu G; Wu M; Levi G; Ferrari N Int J Cancer; 1998 Oct; 78(2):248-54. PubMed ID: 9754659 [TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid- and N-(4-hydroxyphenil)-retinamide-induced growth arrest and apoptosis in orbital fibroblasts in Graves' disease. Pasquali D; Bellastella A; Colantuoni V; Vassallo P; Bonavolontà G; Rossi V; Notaro A; Sinisi AA Metabolism; 2003 Nov; 52(11):1387-92. PubMed ID: 14624395 [TBL] [Abstract][Full Text] [Related]
14. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway. Kitareewan S; Spinella MJ; Allopenna J; Reczek PR; Dmitrovsky E Oncogene; 1999 Oct; 18(42):5747-55. PubMed ID: 10523855 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl)retinamide-induced apoptosis. Hail N; Lotan R Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1293-301. PubMed ID: 11142414 [TBL] [Abstract][Full Text] [Related]
16. The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway. Chun KH; Benbrook DM; Berlin KD; Hong WK; Lotan R Cancer Res; 2003 Jul; 63(13):3826-32. PubMed ID: 12839980 [TBL] [Abstract][Full Text] [Related]
17. Identification of retinoid-modulated proteins in squamous carcinoma cells using high-throughput immunoblotting. Kim HJ; Lotan R Cancer Res; 2004 Apr; 64(7):2439-48. PubMed ID: 15059897 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR). Xia Y; Wong NS; Fong WF; Tideman H Int J Cancer; 2002 Nov; 102(1):7-14. PubMed ID: 12353227 [TBL] [Abstract][Full Text] [Related]
19. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419 [TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells. Sun SY; Yue P; Lotan R Mol Pharmacol; 1999 Mar; 55(3):403-10. PubMed ID: 10051523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]